🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 18 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/12/2002 | 8,50 | 8,57 | 8,48 | 8,54 | -0,99% | 1,06% | 149.000 |
| 26/12/2002 | 8,58 | 8,64 | 8,45 | 8,63 | +0,41% | 2,22% | 138.000 |
| 24/12/2002 | 8,55 | 8,66 | 8,55 | 8,59 | -0,41% | 1,23% | 66.600 |
| 23/12/2002 | 8,42 | 8,66 | 8,42 | 8,63 | +1,47% | 2,91% | 176.000 |
| 20/12/2002 | 8,51 | 8,77 | 8,44 | 8,50 | -1,90% | 3,88% | 299.600 |
| 19/12/2002 | 8,66 | 8,79 | 8,50 | 8,67 | -0,12% | 3,35% | 396.600 |
| 18/12/2002 | 8,49 | 8,90 | 8,24 | 8,68 | +1,94% | 7,71% | 603.200 |
| 17/12/2002 | 8,50 | 8,52 | 8,20 | 8,51 | +0,18% | 3,82% | 173.400 |
| 16/12/2002 | 8,77 | 8,77 | 8,43 | 8,50 | -2,58% | 3,82% | 127.400 |
| 13/12/2002 | 8,75 | 8,80 | 8,63 | 8,72 | -0,97% | 1,94% | 141.800 |
| 12/12/2002 | 8,75 | 9,02 | 8,56 | 8,81 | +0,80% | 5,32% | 652.600 |
| 11/12/2002 | 8,39 | 8,74 | 8,36 | 8,74 | +3,50% | 4,47% | 413.800 |
| 10/12/2002 | 8,60 | 8,61 | 8,25 | 8,44 | -1,86% | 4,19% | 265.800 |
| 09/12/2002 | 8,50 | 8,65 | 8,47 | 8,60 | -0,46% | 2,06% | 190.000 |
| 06/12/2002 | 8,59 | 8,66 | 8,50 | 8,64 | +0,47% | 1,86% | 117.400 |
| 05/12/2002 | 8,55 | 8,67 | 8,48 | 8,60 | +1,53% | 2,22% | 109.000 |
| 04/12/2002 | 8,48 | 8,54 | 8,39 | 8,47 | -0,82% | 1,83% | 99.000 |
| 03/12/2002 | 8,53 | 8,58 | 8,45 | 8,54 | +0,18% | 1,47% | 109.600 |
| 02/12/2002 | 8,64 | 8,75 | 8,47 | 8,53 | -1,27% | 3,30% | 323.200 |
| 29/11/2002 | 8,65 | 8,72 | 8,50 | 8,64 | -0,40% | 2,60% | 69.200 |
| 27/11/2002 | 8,22 | 8,67 | 8,22 | 8,67 | +5,54% | 5,47% | 256.000 |
| 26/11/2002 | 8,48 | 8,48 | 8,20 | 8,22 | -2,78% | 3,30% | 264.400 |
| 25/11/2002 | 8,55 | 8,70 | 8,33 | 8,45 | -0,71% | 4,33% | 290.600 |
| 22/11/2002 | 8,55 | 8,79 | 8,50 | 8,51 | -1,56% | 3,39% | 168.200 |
| 21/11/2002 | 8,54 | 9,12 | 8,50 | 8,65 | +0,93% | 7,26% | 551.000 |
| 20/11/2002 | 8,24 | 8,57 | 8,16 | 8,57 | +4,26% | 4,98% | 319.400 |
| 19/11/2002 | 8,25 | 8,35 | 8,15 | 8,22 | -1,38% | 2,36% | 360.400 |
| 18/11/2002 | 8,31 | 8,48 | 8,17 | 8,33 | +2,52% | 3,73% | 765.800 |
| 15/11/2002 | 8,16 | 8,28 | 7,96 | 8,13 | -1,28% | 3,86% | 237.400 |
| 14/11/2002 | 7,96 | 8,30 | 7,96 | 8,23 | +3,85% | 4,34% | 281.800 |